The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands
P. Slingerland,
Florence P. A. M. Hunsel (),
T. Lieber,
L. Balveren and
J. W. Duijster
Additional contact information
P. Slingerland: Netherlands Pharmacovigilance Centre Lareb
Florence P. A. M. Hunsel: Netherlands Pharmacovigilance Centre Lareb
T. Lieber: Netherlands Pharmacovigilance Centre Lareb
L. Balveren: Netherlands Pharmacovigilance Centre Lareb
J. W. Duijster: Netherlands Pharmacovigilance Centre Lareb
Drug Safety, 2023, vol. 46, issue 12, No 5, 1323-1334
Abstract:
Abstract Introduction The annual reformulation of the seasonal influenza vaccine results in fluctuating frequencies and severity of adverse effects following immunization (AEFIs), which stresses the importance of pharmacovigilance. Also, sex-related factors are known to influence the development of AEFIs. This study aims to describe the difference in incidence and course (i.e., time-to-onset, time-to-recovery, and perceived burden) of AEFIs between males and females after seasonal influenza vaccination. Methods We assessed data from cohort event monitoring studies, which were performed over nine consecutive years (2013–2021), each covering several months during the seasonal influenza campaign in the Netherlands. Participants reported information about AEFIs over a 30-day period in three questionnaires. The effect of sex, age, body mass index, study year, and comorbidities on the incidence of any AEFI, local reactions, fever and the five most reported AEFIs was analyzed using logistic regression. The difference in time-to-onset, time-to-recovery, and perceived burden between males and females was analyzed by the Kruskal–Wallis test. Results The cohort included 7789 participants (53.0% females). Females had around 2.5-fold (p
Date: 2023
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s40264-023-01356-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:46:y:2023:i:12:d:10.1007_s40264-023-01356-7
Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264
DOI: 10.1007/s40264-023-01356-7
Access Statistics for this article
Drug Safety is currently edited by Nitin Joshi
More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().